Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Cools

Showing results (171-180 of 184) with videos related to

Pageof 19
Sort By:
Cancer Cell|January 15, 2020
Loss or Inhibition of Stromal-Derived PlGF Prolongs Survival of Mice with Imatinib-Resistant Bcr-Abl1<sup>+</sup> LeukemiaThomas Schmidt, Behzad Kharabi Masouleh, Sonja Loges, et al.
The New England Journal of Medicine|March 28, 2003
A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndromeJan Cools, Daniel J DeAngelo, Jason Gotlib, et al.
Cancer Cell|June 14, 2011
Loss or inhibition of stromal-derived PlGF prolongs survival of mice with imatinib-resistant Bcr-Abl1(+) leukemiaThomas Schmidt, Behzad Kharabi Masouleh, Sonja Loges, et al.
Nature Genetics|December 25, 2012
Exome sequencing identifies mutation in CNOT3 and ribosomal genes RPL5 and RPL10 in T-cell acute lymphoblastic leukemiaKim De Keersmaecker, Zeynep Kalender Atak, Ning Li, et al.
Cancer|November 28, 2018
Aneuploid acute myeloid leukemia exhibits a signature of genomic alterations in the cell cycle and protein degradation machineryGiorgia Simonetti, Antonella Padella, Italo Farìa do Valle, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 20, 2010
Meta-analysis of neuroblastomas reveals a skewed ALK mutation spectrum in tumors with MYCN amplificationSara De Brouwer, Katleen De Preter, Candy Kumps, et al.
Cancer Cell|April 20, 2005
Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosisRoss L Levine, Martha Wadleigh, Jan Cools, et al.
Nature Communications|July 7, 2021
Oncogenic cooperation between TCF7-SPI1 and NRAS(G12D) requires β-catenin activity to drive T-cell acute lymphoblastic leukemiaQuentin Van Thillo, Jolien De Bie, Janith A Seneviratne, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 26, 2015
Upregulation of MAPK Negative Feedback Regulators and RET in Mutant ALK Neuroblastoma: Implications for Targeted TreatmentIrina Lambertz, Candy Kumps, Shana Claeys, et al.
Nature|February 7, 2026
Author Correction: PHGDH heterogeneity potentiates cancer cell dissemination and metastasisMatteo Rossi, Patricia Altea-Manzano, Margherita Demicco, et al.
Pageof 19

Showing results (171-180 of 184) with videos related to

Sort By:
Pageof 19
Cancer Cell|January 15, 2020
Loss or Inhibition of Stromal-Derived PlGF Prolongs Survival of Mice with Imatinib-Resistant Bcr-Abl1<sup>+</sup> LeukemiaThomas Schmidt, Behzad Kharabi Masouleh, Sonja Loges, et al.
The New England Journal of Medicine|March 28, 2003
A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndromeJan Cools, Daniel J DeAngelo, Jason Gotlib, et al.
Cancer Cell|June 14, 2011
Loss or inhibition of stromal-derived PlGF prolongs survival of mice with imatinib-resistant Bcr-Abl1(+) leukemiaThomas Schmidt, Behzad Kharabi Masouleh, Sonja Loges, et al.
Nature Genetics|December 25, 2012
Exome sequencing identifies mutation in CNOT3 and ribosomal genes RPL5 and RPL10 in T-cell acute lymphoblastic leukemiaKim De Keersmaecker, Zeynep Kalender Atak, Ning Li, et al.
Cancer|November 28, 2018
Aneuploid acute myeloid leukemia exhibits a signature of genomic alterations in the cell cycle and protein degradation machineryGiorgia Simonetti, Antonella Padella, Italo Farìa do Valle, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 20, 2010
Meta-analysis of neuroblastomas reveals a skewed ALK mutation spectrum in tumors with MYCN amplificationSara De Brouwer, Katleen De Preter, Candy Kumps, et al.
Cancer Cell|April 20, 2005
Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosisRoss L Levine, Martha Wadleigh, Jan Cools, et al.
Nature Communications|July 7, 2021
Oncogenic cooperation between TCF7-SPI1 and NRAS(G12D) requires β-catenin activity to drive T-cell acute lymphoblastic leukemiaQuentin Van Thillo, Jolien De Bie, Janith A Seneviratne, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 26, 2015
Upregulation of MAPK Negative Feedback Regulators and RET in Mutant ALK Neuroblastoma: Implications for Targeted TreatmentIrina Lambertz, Candy Kumps, Shana Claeys, et al.
Nature|February 7, 2026
Author Correction: PHGDH heterogeneity potentiates cancer cell dissemination and metastasisMatteo Rossi, Patricia Altea-Manzano, Margherita Demicco, et al.
Pageof 19